{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:57:12Z","timestamp":1794571032918,"version":"4.9.1"},"reference-count":138,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>RATIONALE:<\/jats:title>\n                    <jats:p>Maintaining glycemic control of critically ill patients may impact outcomes such as survival, infection, and neuromuscular recovery, but there is equipoise on the target blood levels, monitoring frequency, and methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>The purpose was to update the 2012 Society of Critical Care Medicine and American College of Critical Care Medicine (ACCM) guidelines with a new systematic review of the literature and provide actionable guidance for clinicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PANEL DESIGN:<\/jats:title>\n                    <jats:p>The total multiprofessional task force of 22, consisting of clinicians and patient\/family advocates, and a methodologist applied the processes described in the ACCM guidelines standard operating procedure manual to develop evidence-based recommendations in alignment with the Grading of Recommendations Assessment, Development, and Evaluation Approach (GRADE) methodology. Conflict of interest policies were strictly followed in all phases of the guidelines, including panel selection and voting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a systematic review for each Population, Intervention, Comparator, and Outcomes question related to glycemic management in critically ill children (\u2265 42\u2009wk old adjusted gestational age to 18 yr old) and adults, including triggers for initiation of insulin therapy, route of administration, monitoring frequency, role of an explicit decision support tool for protocol maintenance, and methodology for glucose testing. We identified the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the GRADE approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak or as a good practice statement. In addition, \u201cIn our practice\u201d statements were included when the available evidence was insufficient to support a recommendation, but the panel felt that describing their practice patterns may be appropriate. Additional topics were identified for future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>This guideline is an update of the guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. It is intended for adult and pediatric practitioners to reassess current practices and direct research into areas with inadequate literature. The panel issued seven statements related to glycemic control in unselected adults (two good practice statements, four conditional recommendations, one research statement) and seven statements for pediatric patients (two good practice statements, one strong recommendation, one conditional recommendation, two \u201cIn our practice\u201d statements, and one research statement), with additional detail on specific subset populations where available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The guidelines panel achieved consensus for adults and children regarding a preference for an insulin infusion for the acute management of hyperglycemia with titration guided by an explicit clinical decision support tool and frequent (\u2264 1\u2009hr) monitoring intervals during glycemic instability to minimize hypoglycemia and against targeting intensive glucose levels. These recommendations are intended for consideration within the framework of the patient\u2019s existing clinical status. Further research is required to evaluate the role of individualized glycemic targets, continuous glucose monitoring systems, explicit decision support tools, and standardized glycemic control metrics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006174","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T09:03:33Z","timestamp":1705655013000},"page":"e161-e181","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":173,"title":["Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024"],"prefix":"10.1097","volume":"52","author":[{"given":"Kimia","family":"Honarmand","sequence":"first","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Mackenzie Health, Vaughan, ON, Canada."},{"name":"GUIDE Canada, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sirimaturos","sequence":"additional","affiliation":[{"name":"System Critical Care Pharmacy Services Leader, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliotte L.","family":"Hirshberg","sequence":"additional","affiliation":[{"name":"Adult and Pediatric Critical Care Specialist, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G.","family":"Bircher","sequence":"additional","affiliation":[{"name":"Department of Nurse Anesthesia, School of Nursing, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S. D.","family":"Agus","sequence":"additional","affiliation":[{"name":"Harvard Medical School and Division Chief, Medical Critical Care, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Emory Critical Care Center, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia R.","family":"Downs","sequence":"additional","affiliation":[{"name":"Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Farrington","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care Pharmacist, New Hanover Regional Medical Center, Wilmington, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado X.","family":"Freire","sequence":"additional","affiliation":[{"name":"Pulmonary Critical Care and Sleep Medicine at the University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Grow","sequence":"additional","affiliation":[{"name":"Kaysville, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Y.","family":"Irving","sequence":"additional","affiliation":[{"name":"Department of Nursing and Clinical Care Services\u2014Critical Care, University of Pennsylvania School of Nursing, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Krinsley","sequence":"additional","affiliation":[{"name":"Director of Critical Care, Emeritus, Vagelos Columbia University College of Physicians and Surgeons, Stamford Hospital, Stamford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lanspa","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Intermountain Medical Center, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah T.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Division of Critical Care, University of Wisconsin School of Medicine & Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nagpal","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Critical Care Western, London Health Sciences Centre, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Preiser","sequence":"additional","affiliation":[{"name":"Medical Director for Research and Teaching, Erasme Hospital, H\u00f4pital Universitaire de Bruxelles, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology, Critical Care and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."},{"name":"Department of Anesthesiology and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[{"name":"School of Medicine, Emory University, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Jacobi","sequence":"additional","affiliation":[{"name":"Lebanon, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients.","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients.","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12871-022-01769-4","article-title":"Glycemic control in critically ill patients with or without diabetes.","volume":"22","author":"Fong","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","article-title":"Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.","volume":"40","author":"Jacobi","year":"2012","journal-title":"Crit Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.2337\/dc23-S016","article-title":"Diabetes care in the hospital: Standards of care in diabetes\u20142023.","volume":"46","author":"El-Sayed","year":"2023","journal-title":"Diabetes Care"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American Association of Clinical Endocrinology clinical practice guideline: Developing a diabetes mellitus comprehensive care plan-2022 update.","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr Pract"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","article-title":"Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.","volume":"37","author":"Falciglia","year":"2009","journal-title":"Crit Care Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2337\/diabetes.53.8.2079","article-title":"Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.","volume":"53","author":"Stentz","year":"2004","journal-title":"Diabetes"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3949\/ccjm.89a.20171","article-title":"Glycemic control in the critically ill: Less is more.","volume":"89","author":"Alhatemi","year":"2022","journal-title":"Cleve Clin J Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jcrc.2006.08.002","article-title":"Lowering of glucose in critical care: A randomized pilot trial.","volume":"22","author":"McMullin","year":"2007","journal-title":"J Crit Care"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s00134-009-1585-2","article-title":"A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study.","volume":"35","author":"Preiser","year":"2009","journal-title":"Intensive Care Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1097\/CCM.0b013e31818f21aa","article-title":"Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients.","volume":"36","author":"Arabi","year":"2008","journal-title":"Crit Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00134-011-2458-z","article-title":"Dyslipidemia: A prospective controlled randomized trial of intensive glycemic control in sepsis.","volume":"38","author":"Cappi","year":"2012","journal-title":"Intensive Care Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/cc7017","article-title":"Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: A randomised clinical trial.","volume":"12","author":"De La Rosa","year":"2008","journal-title":"Crit Care"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/cc11299","article-title":"Moderate glucose control results in less negative nitrogen balances in medical intensive care unit patients: A randomized, controlled study.","volume":"16","author":"Hsu","year":"2012","journal-title":"Crit Care"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00134-013-3189-0","article-title":"Tight computerized versus conventional glucose control in the ICU: A randomized controlled trial.","volume":"40","author":"Kalfon","year":"2014","journal-title":"Intensive Care Med"},{"key":"R21-20250502","first-page":"289","article-title":"A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.","volume":"8","author":"Mitchell","year":"2006","journal-title":"Crit Care Resusc"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU.","volume":"354","author":"van den Berghe","year":"2006","journal-title":"N Engl J Med"},{"key":"R23-20250502","first-page":"121","article-title":"Glycaemic control and outcome in general intensive care: The East Anglian GLYCOGENIC study.","volume":"18","author":"Mackenzie","year":"2008","journal-title":"Br J Intensive Care"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3945\/ajcn.110.005074","article-title":"Permissive underfeeding and intensive insulin therapy in critically ill patients: A randomized controlled trial.","volume":"93","author":"Arabi","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: A randomized controlled trial.","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijnurstu.2009.01.004","article-title":"Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: A randomized controlled trial.","volume":"46","author":"Yang","year":"2009","journal-title":"Int J Nurs Stud"},{"key":"R27-20250502","first-page":"904","article-title":"Intensive insulin therapy in severe traumatic brain injury: A randomized trial.","volume":"68","author":"Coester","year":"2010","journal-title":"J Trauma"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"R790","DOI":"10.1186\/cc3911","article-title":"Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: A randomized controlled trial [ISRCTN95608630].","volume":"9","author":"Hoedemaekers","year":"2005","journal-title":"Crit Care"},{"key":"R29-20250502","first-page":"140","article-title":"Insulin therapy of hyperglycemia in intensive care.","volume":"9","author":"Farah","year":"2007","journal-title":"Israel Med Assn J"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/aer.AER_62_20","article-title":"The efficacy of intensive versus conventional insulin therapy in reducing mortality and morbidity in medical and surgical critically ill patients: A randomized controlled study.","volume":"14","author":"Gupta","year":"2020","journal-title":"Anesth Essays Res"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"e6458","DOI":"10.1097\/MD.0000000000006458","article-title":"Intensive insulin therapy for preventing postoperative infection in patients with traumatic brain injury: A randomized controlled trial.","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"Suppl 2","key":"R32-20250502","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4158\/EP.10.S2.46","article-title":"Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.","volume":"10","author":"Grey","year":"2004","journal-title":"Endocr Pract"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.egja.2015.05.002","article-title":"Application of conventional blood glucose control strategy in surgical ICU in developing countries: Is it beneficial?","volume":"32","author":"Hamimy","year":"2019","journal-title":"Egypt J Anaesth"},{"key":"R34-20250502","first-page":"157","article-title":"The efficacy of intensive glucose management on hospitalized critically ill patients associated mortality rate in intensive care unit.","volume":"17","author":"Taslimi","year":"2009","journal-title":"DARU J Pharm Sci"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/dc15-0303","article-title":"Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial.","volume":"38","author":"Umpierrez","year":"2015","journal-title":"Diabetes Care"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4037\/ajcc2005.14.5.370","article-title":"Intensive versus modified conventional control of blood glucose level in medical intensive care patients: A pilot study.","volume":"14","author":"Bland","year":"2005","journal-title":"Am J Crit Care"},{"key":"R37-20250502","first-page":"496","article-title":"A comparative study of efficacy of intensive insulin therapy versus conventional method on mortality and morbidity of critically ill patients.","volume":"27","author":"Mahmoodpoor","year":"2011","journal-title":"Pak J Med Sci"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1590\/S0004-282X2007000500001","article-title":"Intensive insulin therapy versus conventional glycemic control in patients with acute neurological injury: A prospective controlled trial.","volume":"65","author":"Azevedo","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/CCM.0b013e31819542da","article-title":"Tight glycemic control may favor fibrinolysis in patients with sepsis.","volume":"37","author":"Savioli","year":"2009","journal-title":"Crit Care Med"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"439","DOI":"10.20452\/pamw.733","article-title":"The efficacy and safety of glucose control algorithms in intensive care: A pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial.","volume":"119","author":"Henderson","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis.","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S1807-59322009000100010","article-title":"Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: A randomized controlled trial.","volume":"64","author":"Chan","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"R43-20250502","first-page":"S86","article-title":"A multicentre study on intensive insulin therapy of severe sepsis and septic shock patients in ICU-collaborative study group on IIT in Zhejiang Province, China.","volume":"35","author":"Jin","year":"2009","journal-title":"Intensive Care Med"},{"key":"R44-20250502","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s11605-011-1654-z","article-title":"Intensive versus conventional insulin therapy in nondiabetic patients receiving parenteral nutrition after D2 gastrectomy for gastric cancer: A randomized controlled trial.","volume":"15","author":"Cao","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"R45-20250502","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/ALN.0b013e318198004b","article-title":"Safety and efficacy of intensive insulin therapy in critical neurosurgical patients.","volume":"110","author":"Bilotta","year":"2009","journal-title":"Anesthesiology"},{"key":"R46-20250502","first-page":"420","article-title":"Comparison of intensive insulin therapy versus conventional glucose control in traumatic brain injury patients on parenteral nutrition: A pilot randomized clinical trial.","volume":"19","author":"Mousavi","year":"2014","journal-title":"J Res Med Sci"},{"key":"R47-20250502","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jtcvs.2011.10.070","article-title":"Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: A prospective randomized controlled trial.","volume":"143","author":"Desai","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R48-20250502","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc13-1771","article-title":"Intensive versus intermediate glucose control in surgical intensive care unit patients.","volume":"37","author":"Okabayashi","year":"2014","journal-title":"Diabetes Care"},{"key":"R49-20250502","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1186\/cc8202","article-title":"Intensive insulin treatment improves forearm blood flow in critically ill patients: A randomized parallel design clinical trial.","volume":"13","author":"Zuran","year":"2009","journal-title":"Crit Care"},{"key":"R50-20250502","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00134-015-3757-6","article-title":"Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: Long-term follow-up of a subgroup of patients from the NICE-SUGAR study.","volume":"41","author":"Finfer","year":"2015","journal-title":"Intensive Care Med"},{"key":"R51-20250502","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/s13054-014-0498-9","article-title":"Effects of tight computerized glucose control on neurological outcome in severely brain injured patients: A multicenter sub-group analysis of the randomized-controlled open-label CGAO-REA study.","volume":"18","author":"Cinotti","year":"2014","journal-title":"Crit Care"},{"key":"R52-20250502","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/eurheartj\/ehi855","article-title":"Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life.","volume":"27","author":"Ingels","year":"2006","journal-title":"Eur Heart J"},{"key":"R53-20250502","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJMoa2304855","article-title":"Tight blood-glucose control without early parenteral nutrition in the ICU.","volume":"389","author":"Gunst","year":"2023","journal-title":"N Engl J Med"},{"key":"R54-20250502","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1097\/01.CCM.0000282073.98414.4B","article-title":"Severe hypoglycemia in critically ill patients: Risk factors and outcomes.","volume":"35","author":"Krinsley","year":"2007","journal-title":"Crit Care Med"},{"key":"R55-20250502","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4065\/mcp.2009.0394","article-title":"Hypoglycemia and outcome in critically ill patients.","volume":"85","author":"Egi","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R56-20250502","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients.","volume":"367","author":"Finfer","year":"2012","journal-title":"N Engl J Med"},{"key":"R57-20250502","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00134-016-4216-8","article-title":"Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality.","volume":"42","author":"Egi","year":"2016","journal-title":"Intensive Care Med"},{"key":"R58-20250502","first-page":"309","article-title":"Inflammation and oxidative stress in cardiac surgery patients treated to intensive versus conservative glucose targets.","volume":"102","author":"Reyes-Umpierrez","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-20250502","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1210\/jc.2015-1959","article-title":"Perioperative tight glucose control reduces postoperative adverse events in nondiabetic cardiac surgery patients.","volume":"100","author":"Blaha","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R60-20250502","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2337\/dc15-1817","article-title":"Diabetes and the association of postoperative hyperglycemia with clinical and economic outcomes in cardiac surgery.","volume":"39","author":"Greco","year":"2016","journal-title":"Diabetes Care"},{"key":"R61-20250502","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jtcvs.2016.01.060","article-title":"Prevention and management of sternal wound infections.","volume":"152","author":"Lazar","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R62-20250502","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","article-title":"Guidelines for perioperative care in cardiac surgery: Enhanced recovery after surgery society recommendations.","volume":"154","author":"Engelman","year":"2019","journal-title":"JAMA Surg"},{"key":"R63-20250502","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc12547","article-title":"Diabetic status and the relationship of the 3 domains of glycemic control to mortality in critically ill patients: An international multi-center cohort study.","volume":"17","author":"Krinsley","year":"2013","journal-title":"Crit Care"},{"key":"R64-20250502","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc12572","article-title":"The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: A retrospective cohort study.","volume":"17","author":"Sechterberger","year":"2013","journal-title":"Crit Care"},{"key":"R65-20250502","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00134-014-3287-7","article-title":"Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality.","volume":"40","author":"Plummer","year":"2014","journal-title":"Intensive Care Med"},{"key":"R66-20250502","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2015-2660","article-title":"Relative hyperglycemia, a marker of critical illness: Introducing the stress hyperglycemia ratio.","volume":"100","author":"Roberts","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-20250502","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/CCM.0000000000004599","article-title":"The interaction of acute and chronic glycemia on the relationship of hyperglycemia, hypoglycemia, and glucose variability to mortality in the critically ill.","volume":"48","author":"Krinsley","year":"2020","journal-title":"Crit Care Med"},{"key":"R68-20250502","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/CCM.0000000000004213","article-title":"Relative hypoglycemia in diabetic patients with critical illness.","volume":"48","author":"Kwan","year":"2020","journal-title":"Crit Care Med"},{"key":"R69-20250502","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1097\/CCM.0000000000005490","article-title":"Relative hypoglycemia and lower hemoglobin A1C-adjusted time in band are strongly associated with increased mortality in critically ill patients.","volume":"50","author":"Krinsley","year":"2022","journal-title":"Crit Care Med"},{"key":"R70-20250502","article-title":"The glycemic ratio is strongly and independently associated with mortality in the critically ill.","author":"Roberts","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"R71-20250502","first-page":"1271","article-title":"Individualised versus conventional glucose control in critically-ill patients: The CONTROLING study-a randomized clinical trial.","volume":"47","author":"Bohe","year":"2021","journal-title":"Intensive Care Med"},{"key":"R72-20250502","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jdiacomp.2017.01.003","article-title":"Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy.","volume":"31","author":"Cardona","year":"2017","journal-title":"J Diabetes Complications"},{"key":"R73-20250502","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jcpt.12012","article-title":"Subcutaneous versus intravenous insulin therapy for glucose control in non-diabetic trauma patients. A randomized controlled trial.","volume":"38","author":"Aron","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"R74-20250502","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcrc.2009.05.005","article-title":"A randomized controlled trial comparing a computer-assisted insulin infusion protocol with a strict and a conventional protocol for glucose control in critically ill patients.","volume":"24","author":"Cavalcanti","year":"2009","journal-title":"J Crit Care"},{"key":"R75-20250502","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/dc05-2353","article-title":"Intensive insulin therapy in the intensive care unit: Assessment by continuous glucose monitoring.","volume":"29","author":"De Block","year":"2006","journal-title":"Diabetes Care"},{"key":"R76-20250502","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/1060028019841363","article-title":"Intravenous insulin infusion protocol compared with subcutaneous insulin for the management of hyperglycemia in critically ill adults.","volume":"53","author":"Tran","year":"2019","journal-title":"Ann Pharmacother"},{"key":"R77-20250502","first-page":"A18","article-title":"Patient safety improvements with IV insulin compared to subcutaneous insulin in the ICU.","volume":"14","author":"Rabinovich","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"R78-20250502","first-page":"1660","article-title":"Effectiveness of subcutaneous insulin regimens versus intravenous insulin infusion protocols on glycemic control in critically ill patients.","volume":"4","author":"Huntt","year":"2021","journal-title":"J Am Coll Clin Pharm"},{"key":"R79-20250502","doi-asserted-by":"crossref","first-page":"1205121","DOI":"10.1155\/2018\/1205121","article-title":"Factors affecting the absorption of subcutaneously administered insulin: Effect on variability.","volume":"2018","author":"Gradel","year":"2018","journal-title":"J Diabetes Res"},{"key":"R80-20250502","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s13054-014-0453-9","article-title":"Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: A randomized controlled trial.","volume":"18","author":"Boom","year":"2014","journal-title":"Crit Care"},{"key":"R81-20250502","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc09-1352","article-title":"Real-time continuous glucose monitoring in critically ill patients: A prospective randomized trial.","volume":"33","author":"Holzinger","year":"2010","journal-title":"Diabetes Care"},{"key":"R82-20250502","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/dia.2015.0151","article-title":"Randomized evaluation of glycemic control in the medical intensive care unit using real-time continuous glucose monitoring (REGIMEN Trial).","volume":"17","author":"De Block","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"R83-20250502","doi-asserted-by":"crossref","first-page":"e12138","DOI":"10.1097\/MD.0000000000012138","article-title":"Continuous glucose monitoring system can improve the quality of glucose control and glucose variability compared with point-of-care measurement in critically ill patients: A randomized controlled trial.","volume":"97","author":"Lu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R84-20250502","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/CCM.0000000000003157","article-title":"Near-continuous glucose monitoring makes glycemic control safer in ICU patients.","volume":"46","author":"Preiser","year":"2018","journal-title":"Crit Care Med"},{"key":"R85-20250502","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/cc10786","article-title":"Perioperative glycemic control with a computerized algorithm versus conventional glycemic control.","volume":"16","author":"Punke","year":"2012","journal-title":"Crit Care"},{"key":"R86-20250502","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/CCM.0000000000003214","article-title":"Glucose monitoring in the ICU: What is really needed?","volume":"46","author":"Long","year":"2018","journal-title":"Crit Care Med"},{"key":"R87-20250502","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/19322968221137338","article-title":"Continuous glucose monitoring within hospital: A scoping review and summary of guidelines from the Joint British Diabetes Societies for Inpatient Care.","volume":"17","author":"Avari","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"R88-20250502","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-017-1784-0","article-title":"Continuous glucose monitoring in the ICU: Clinical considerations and consensus.","volume":"21","author":"Krinsley","year":"2017","journal-title":"Crit Care"},{"key":"R89-20250502","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: An international consensus statement.","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R90-20250502","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10877-012-9364-y","article-title":"Decision support for optimized blood glucose control and nutrition in a neurotrauma intensive care unit: Preliminary results of clinical advice and prediction accuracy of the Glucosafe system.","volume":"26","author":"Pielmeier","year":"2012","journal-title":"J Clin Monit Comput"},{"key":"R91-20250502","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00134-008-1236-z","article-title":"Intensive insulin therapy: Enhanced model predictive control algorithm versus standard care.","volume":"35","author":"Cordingley","year":"2009","journal-title":"Intensive Care Med"},{"key":"R92-20250502","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/BCR.0b013e31820aaebf","article-title":"Computer decision support software safely improves glycemic control in the burn intensive care unit: A randomized controlled clinical study.","volume":"32","author":"Mann","year":"2011","journal-title":"J Burn Care Res"},{"key":"R93-20250502","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00134-008-1033-8","article-title":"Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients.","volume":"34","author":"Pachler","year":"2008","journal-title":"Intensive Care Med"},{"key":"R94-20250502","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/CCM.0000000000002252","article-title":"Bedside glucose monitoring\u2014is it safe? A new, regulatory-compliant risk assessment evaluation protocol in critically ill patient care settings*.","volume":"45","author":"Dubois","year":"2017","journal-title":"Crit Care Med"},{"key":"R95-20250502","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc12838","article-title":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: A randomized controlled trial.","volume":"17","author":"Leelarathna","year":"2013","journal-title":"Crit Care"},{"key":"R96-20250502","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/dc12-0584","article-title":"LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: The LOGIC-1 single-center, randomized, controlled clinical trial.","volume":"36","author":"Van Herpe","year":"2013","journal-title":"Diabetes Care"},{"key":"R97-20250502","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4103\/0366-6999.213422","article-title":"Comparison of space glucose control and routine glucose management protocol for glycemic control in critically ill patients: A prospective, randomized clinical study.","volume":"130","author":"Xu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"R98-20250502","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4037\/ajcc2012956","article-title":"Effect of a computerized insulin dose calculator on the process of glycemic control.","volume":"21","author":"Dumont","year":"2012","journal-title":"Am J Crit Care"},{"key":"R99-20250502","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2337\/dc08-1851","article-title":"Comparison of three protocols for tight glycemic control in cardiac surgery patients.","volume":"32","author":"Blaha","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"R100-20250502","first-page":"270","article-title":"The effects of computer regulated continuous blood glucose management in diabetic patients underwent cardiac surgery.","volume":"4","author":"Iwasaka","year":"2016","journal-title":"Intensive Care Med Exp"},{"key":"R101-20250502","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.dsx.2021.03.024","article-title":"A prospective randomized trial comparing computerized columnar insulin dosing chart (the Atlanta protocol) versus the Joint British Diabetes Societies for inpatient care protocol in management of hyperglycemia in patients with acute coronary syndrome admitted to cardiac care unit in Alexandria, Egypt.","volume":"15","author":"Zeitoun","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R102-20250502","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1932296821995568","article-title":"Monitoring the impact of aggressive glycemic intervention during critical care after cardiac surgery with a glycemic expert system for nurse-implemented euglycemia: The MAGIC GENIE Project.","volume":"15","author":"Rao","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R103-20250502","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1932296820974767","article-title":"Improving hospital glucometrics, workflow, and outcomes with a computerized intravenous insulin dose calculator built into the electronic health record.","volume":"15","author":"Shelden","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R104-20250502","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/pdi.1960040306","article-title":"Glycosuria in childhood.","volume":"4","author":"Challen","year":"1987","journal-title":"Pract Diabetes Int"},{"key":"R106-20250502","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMoa1612348","article-title":"Tight glycemic control in critically ill children.","volume":"376","author":"Agus","year":"2017","journal-title":"N Engl J Med"},{"key":"R107-20250502","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1302564","article-title":"A randomized trial of hyperglycemic control in pediatric intensive care.","volume":"370","author":"Macrae","year":"2014","journal-title":"N Engl J Med"},{"key":"R108-20250502","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/rccm.201002-0190OC","article-title":"Intensive insulin therapy in severely burned pediatric patients: A prospective randomized trial.","volume":"182","author":"Jeschke","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R109-20250502","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1206044","article-title":"Tight glycemic control versus standard care after pediatric cardiac surgery.","volume":"367","author":"Agus","year":"2012","journal-title":"N Engl J Med"},{"key":"R110-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18260","article-title":"A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): A randomised controlled trial.","volume":"18","author":"Macrae","year":"2014","journal-title":"Health Technol Assess"},{"key":"R111-20250502","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.athoracsur.2010.03.093","article-title":"Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery.","volume":"90","author":"Vlasselaers","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 1","key":"R112-20250502","first-page":"A47","article-title":"Use of continuous glucose monitoring to achieve target glucose levels in the ICU.","volume":"64","author":"Steil","year":"2015","journal-title":"Diabetes"},{"key":"R113-20250502","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpeds.2019.10.055","article-title":"Long-term neurobehavioral and quality of life outcomes of critically ill children after glycemic control.","volume":"218","author":"Biagas","year":"2020","journal-title":"J Pediatr"},{"key":"R114-20250502","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","article-title":"The Health Utilities Index (HUI\u00ae): Concepts, measurement properties and applications.","volume":"1","author":"Horsman","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R115-20250502","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(09)60044-1","article-title":"Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study.","volume":"373","author":"Vlasselaers","year":"2009","journal-title":"Lancet"},{"key":"R116-20250502","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/CIRCULATIONAHA.113.008124","article-title":"Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: A secondary analysis of the safe pediatric euglycemia after cardiac surgery trial.","volume":"129","author":"Agus","year":"2014","journal-title":"Circulation"},{"key":"R117-20250502","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpeds.2016.03.048","article-title":"Impact of tight glycemic control on neurodevelopmental outcomes at 1 year of age for children with congenital heart disease: A randomized controlled trial.","volume":"174","author":"Sadhwani","year":"2016","journal-title":"J Pediatr"},{"key":"R118-20250502","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12887-022-03556-z","article-title":"Impact of tight glycemic control and hypoglycemia after pediatric cardiac surgery on neurodevelopmental outcomes at three years of age: Findings from a randomized clinical trial.","volume":"22","author":"Sadhwani","year":"2022","journal-title":"BMC Pediatr"},{"key":"R119-20250502","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1164\/rccm.202210-1988LE","article-title":"Tight glycemic control, inflammation, and the ICU: Evidence for heterogeneous treatment effects in two randomized controlled trials.","volume":"207","author":"Zinter","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R120-20250502","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/PCC.0b013e31821926a5","article-title":"Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control.","volume":"12","author":"Steil","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R121-20250502","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13054-017-1799-6","article-title":"Software-guided versus nurse-directed blood glucose control in critically ill patients: The LOGIC-2 multicenter randomized controlled clinical trial.","volume":"21","author":"Dubois","year":"2017","journal-title":"Crit Care"},{"key":"R122-20250502","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4037\/ajcc2021725","article-title":"Nurses\u2019 perceptions of workload burden in pediatric critical care.","volume":"30","author":"Lebet","year":"2021","journal-title":"Am J Crit Care"},{"key":"R123-20250502","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/PCC.0b013e3181e88cfb","article-title":"Comparison of the effectiveness and safety of two insulin infusion protocols in the management of hyperglycemia in critically ill children.","volume":"11","author":"Faraon-Pogaceanu","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R124-20250502","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.7326\/0003-4819-114-12-1020","article-title":"Fingerstick glucose determination in shock.","volume":"114","author":"Atkin","year":"1991","journal-title":"Ann Intern Med"},{"key":"R125-20250502","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/cc12567","article-title":"Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: Systematic review.","volume":"17","author":"Inoue","year":"2013","journal-title":"Crit Care"},{"key":"R127-20250502","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4158\/EP.ep.14.3.337","article-title":"Pseudohypoglycemia: A cause for unreliable finger-stick glucose measurements.","volume":"14","author":"El Khoury","year":"2008","journal-title":"Endocr Pract"},{"key":"R128-20250502","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1177\/193229681300700516","article-title":"Evaluation of point-of-care blood glucose measurements in patients with diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome admitted to a critical care unit.","volume":"7","author":"Corl","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"R129-20250502","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/193229681000400301","article-title":"The Food and Drug Administration is now preparing to establish tighter performance requirements for blood glucose monitors.","volume":"4","author":"Klonoff","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"R130-20250502","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1932296819898277","article-title":"Comparison of accuracy guidelines for hospital glucose meters.","volume":"14","author":"Bowman","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"R131-20250502","first-page":"4757","article-title":"Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: A meta-analysis.","volume":"14","author":"Yao","year":"2022","journal-title":"Am J Transl Res"},{"key":"R132-20250502","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/1932296820954163","article-title":"Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline.","volume":"14","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"R133-20250502","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2337\/dc20-2386","article-title":"Continuous glucose monitoring in the operating room and cardiac intensive care unit.","volume":"44","author":"Perez-Guzman","year":"2021","journal-title":"Diabetes Care"},{"key":"R134-20250502","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/1932296817706151","article-title":"Consensus statement on inpatient use of continuous glucose monitoring.","volume":"11","author":"Wallia","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"R136-20250502","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/dc20-2219","article-title":"Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic.","volume":"44","author":"Agarwal","year":"2021","journal-title":"Diabetes Care"},{"key":"R137-20250502","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/dc20-2085","article-title":"Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: Proof of concept.","volume":"44","author":"Davis","year":"2021","journal-title":"Diabetes Care"},{"key":"R138-20250502","doi-asserted-by":"crossref","first-page":"e4007","DOI":"10.1210\/clinem\/dgab409","article-title":"Use of continuous glucose monitor in critically ill Covid-19 patients requiring insulin infusion: An observational study.","volume":"106","author":"Faulds","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R139-20250502","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11892-023-01503-5","article-title":"Implementation of continuous glucose monitoring, a scoping review.","volume":"23","author":"Faulds","year":"2023","journal-title":"Curr Diabetes Rep"},{"key":"R140-20250502","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/1932296815587013","article-title":"Why have so many intravascular glucose monitoring devices failed?","volume":"9","author":"Smith","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"R141-20250502","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/19322968231191104","article-title":"A consensus statement for continuous glucose monitoring metrics for inpatient clinical trials.","volume":"17","author":"Spanakis","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"R142-20250502","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11096-021-01325-z","article-title":"Safety and efficacy of transitioning from intravenous to subcutaneous insulin in critically ill patients.","volume":"44","author":"Alshaya","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"R143-20250502","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/ds16-0042","article-title":"Interventions to improve adherence to a hypoglycemia protocol.","volume":"30","author":"Destree","year":"2017","journal-title":"Diabetes Spectr"},{"key":"R144-20250502","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4037\/ccn2019876","article-title":"Reducing hypoglycemia in critical care patients using a nurse-driven root cause analysis process.","volume":"39","author":"Shea","year":"2019","journal-title":"Crit Care Nurse"},{"key":"R145-20250502","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/CCM.0000000000005171","article-title":"Pathophysiologic signature of impending ICU hypoglycemia in bedside monitoring and electronic health record data: Model development and external validation.","volume":"50","author":"Horton","year":"2022","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:07:06Z","timestamp":1746191226000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006174","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}